Skip to main content

Ondo 2020: Mimiko is my bogus enemy, he remains so forever — Gov Akeredolu (VIDEO)

Ondo 2020: Mimiko is my bogus enemy, he remains so forever — Gov Akeredolu (VIDEO)
Akeredolu
Former Governor of Ondo State, Olusegun Mimiko(left) and incumbent Rotimi Akeredolu.

By Idowu Bankole

Ondo State governor, Arakurin Rotimi Akeredolu has accused the former governor  Ondo state, Olusegun Mimiko and former Chief Judge of the State, Justice Sehinde Kumuyi of betrayal, referring to them as his bogus enemies forever.

Speaking on Channels Television Sunday Politics Programme, Governor Akeredolu stated that it is now established that his predecessor is his bogus enemy for choosing a path to stab him in the back.

Also read: Chaos as Boko Haram/ISWAP executes its own ‘governor of Lake Chad’ in power struggle

According to Akeredolu, “I took him as a friend, and for me, I will make it clear. I am not somebody that hide my feelings, me he is a bogus enemy so that is established now, a reference to him as my friend will probably not be right.

“To me, he is a bogus enemy, and he remains so for life. It is better for us to go our separate ways because with friends like him, you don’t need an enemy. So it is not the issue of politics, you don’t play politics, you play this high level of betrayal.

“It is not what you need in politics so for me, I am not interested in this kind of politics. So for me, if he thinks he is playing politics he is fooling himself.”

“For me, I am human and I want to have somebody as my friend and I can tell you that two of them, Mimiko and Kumuyi, for me, they are my bogus enemies, and they will probably remain so forever and I don’t want a reference to him as my friend. Mimiko is not a friend.”

Governor Akeredolu also clears the air on the former Chief Justice of the state, Justice Sehinde Kumuyi when he was asked those he referred to as his bogus enemies.

“There is no need for me to start mentioning names here but if you want I will tell you. There is one man who was a former chief Judge here. He is the one called justice Sehinde Kumuyi.

“To me, both of them are bogus enemies and my mind is made up about them and is not going to change and I hope God will forgive me because they have decided to choose a path to stab me at the back.But I am going to survive it.

“I can tell both Mimiko and Sehinde, wherever they are listening to me, that I will survive it, and they will regret their action for life.”

SEE VIDEO HERE: 

Sources in the state revealed that the revelation from the governor is not unconnected with the fact that the Zenith Labour Party, ZLP, candidate, Ajayi Agboola, who is also the current deputy governor of the state, is running to be governor on a political platform whose leader is Olusegun Mimiko.

“Their relationship became strained shortly after Ajayi defected to ZLP from the PDP, fueling speculations of wide support from the immediate past governor of the state, Olusegun Mimiko and his followers,” the sources added.

Vanguard News

The post Ondo 2020: Mimiko is my bogus enemy, he remains so forever — Gov Akeredolu (VIDEO) appeared first on Vanguard News.


by Bankole via Vanguard News https://ift.tt/3cJEA58 Best Known Member of the Cabinet Wikipedia
Labels:

Comments

Post a Comment

Popular posts from this blog

Effective Data Governance: IIM-Africa inks partnership deal with Data Management University

President/Chairman of the governing council of IIM-Africa, Dr. Oyedokun Oyewole has said that effective data governance strategy has become more essential for the survival and sustenance of government and businesses, especially with the sudden outbreak of COVID-19 Pandemic. Oyewole said there is the need to ensure that the right policies, processes, technology, and people are in place to effectively manage data while complying with legal and regulatory requirements. He said that as part of the IIM Africa’s commitments towards ensuring global best practices, it has entered into a long-term partnership with DataManagementU.com to bring the finest data management training to industries across Africa. READ ALSO:  COVID-19: Foreign affairs minister says first set of Nigerians abroad to be evacuated soon According to the IIM President, the alliance is expected to provide members of the Institute and other professionals across Africa, high standards, internationally-recognized learn...
Post a Comment
Read more

Naomi Osaka’s statement about withdrawing from French Open

Japan’s Naomi Osaka returns the ball to Romania’s Patricia Maria Tig during their first round match of the French open tennis tournament at the Roland Garros stadium Sunday, May 30, 2021 in Paris. (AP Photo/Christophe Ena) Naomi Osaka tweeted the following statement announcing her withdrawal from the French Open on Monday: “Hey everyone, this isn’t a situation I ever imagined or intended when I posted a few days ago. I think now the best thing for the tournament, the other players and my well-being is that I withdraw so that everyone can get back to focusing on the tennis going on in Paris. ”I never wanted to be a distraction and I accept that my timing was not idea and my message could have been clearer. ”More importantly I would never trivialize mental health or use the term lightly. The truth is that I have suffered long bouts of depression since the US Open in 2018 and I have had a really hard time coping with that. Anyone that knows me knows I’m introverted, and anyone tha...
Post a Comment
Read more

Remdesivir: The COVID-19 drug helping patients recover faster

A vial of the investigational drug remdesivir is visually inspected at a Gilead manufacturing site in the United States. PHOTO: AP Remdesivir has been shown to speed up recovery times for patients with COVID-19 in a major US-led trial, becoming the first drug with proven benefit against the disease. Here is what you need to know. – What is remdesivir? – Remdesivir is an experimental, broad spectrum antiviral made by US pharmaceutical Gilead Sciences that was first developed to treat Ebola, a viral hemorrhagic fever. It showed early promise in a primate study in 2016 and was later rolled out for a major trial in the Democratic Republic of Congo, where it was compared against three other medicines. That study concluded in 2019 when it was discontinued because it did not boost survival rates as greatly as two monoclonal antibody drugs, which are lab-engineered immune system proteins. In February, the US National Institute of Allergy and Infectious Diseases (NIAID) announced ...
Post a Comment
Read more